BioNTech to Raise USD 250 Million in Private Placement

    NEXT STORY
    Tiziana Life Sciences Announces Agreement with STC Biologics for GMP Manufacturing of an anti-Interleukin-6-Receptor Monoclonal Antibody for Clinical Studies in Patients with COVID-19
    PREV STORY
    Press release Oncology Venture signs agreement to out-license two pipeline assets as part of prioritized portfolio strategy
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    PREMIA and AmoyDx Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network

    author_avatar
    NASDAQ Market News

    Leading BioSciences Reports Positive Interim Results from Phase 2 Trial of LB1148 in Patients Undergoing Major Surgery

    Novel Gastroprotective Treatment Demonstrates 3.2 Day Decrease in Hospital Length of Stay Following Surgery ...

    author_avatar
    NASDAQ Market News

    Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidates

    author_avatar
    NASDAQ Market News